Nuper, Jymed scriptor Peptide productio facilitas, Hubei Jianxiang Biopharmaceutical Co., Ltd., accepit duo publica documenta edita ab Hubei provinciarum medicamentis administratione, in "E Gmp Gmp 2024-260) Et "Export to EU activa pharmaceutical ingredientia (API) Certificate "(WC libellum, No. HB240039).
His documentis confirmet quod A102 productio linea in officina A102 (nam productio oxytocin et semaglutide Apis) et A092 productio linea in officina A092 (ad ATLIPRESS API in Workshop A092 (pro productio Sinis scriptor GMP Signs in Hubei in Sinis in Sinis est in Gmp Sina in Sinis in Sinis in Gmp, quod est equivalent ad Sina in GMP Signs in Hubei in Sinis in Sinis in Sinis in GMP Sinis est in Sina in GMP, quod est equivalent in Sina in Gmp Signs in Sina in Sinis est ad Hubei, quod est equivalent ad Sina in GMP Signs in Hubei, qui in Sinis in Sina in Gmp Sina in Sina in Gmp, quod est in Sina EU, Mundi Salus Organization (qui) et Ich Q7 GMP requisitis pro Pharmaceuticals.
In inspectionem concludi cum obsequio, significans quod Hubei Jianxiang scriptor productio qualis administratione et regulatory exercitia occursum domesticis excelsis signa. Hoc progressionem erit auxilium Hubei Jianxiang est expansion in global foro, praecipue in EU forum: augendae Customer fiducia, nutritius et distributio peptide, secundum pharmaca incrementum. Ut International Market Demand crescit, Hubei Jianxiang erit melius positus in occursum necessitates in global customers cum summus qualitas products et servicia.
De jymmed
Founded in MMIX, Shenzhen jymmed Technology Co., Ltd. est a biotechnology turba specialiter in independens investigationis, progressionem, productio, et Sales Peptide products, latere consuetudine peptide R & D et vestibulum officia. In turma offert super XX peptide apis, cum quinque products, inter semaglutide et Tirzepatide, habens feliciter complevit US FDA DMF limatura.
Et Hubei JX facilius features X productio lineas ad peptide apis (including gubernator-scale lineae), quod propinquos meos CGMP signa US, EU, Sinis. Et facilitas operatur comprehensive pharmaceutical qualis administratione ratio et EHS (environmental, salutem et salus) procuratio ratio. Hoc est Transierunt NMPA publica GMP inspectiones et EHS audits conducted a ducens global clients.
Core Services
- Domesticis et Internationalis Peptide API Registration
- VETERINARIUS et medicamine peptides
- Custom peptide synthesis, cro, CMO, et OEM Services
- PDC (Peptide Conjugates), inter peptide, Radionuclide, peptide-parva molecule, peptide-dapibus, et peptide-rna conjugat
Contactus notitia
Oratio:8th & 9th contignationibus, aedificationem I, Shenzhen biomedical innovation Industrial Park, Jin Hui Road XIV, Kengzi Street, Pingshan District, Shenzhen, Sina
Internationalis API Inquiries:
+ 86-755-26612112 | 86-15013529272
Nam domesticis medicamine peptide rudis materiae:
+ 86-755-26612112 | 86-15013529272
Nam domesticis API adnotatione et CDmo Services:
86-15818682250
Website: www.jymedtech.com
Post tempus: Jan-10-2025
